{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T20:07:31Z","timestamp":1772136451776,"version":"3.50.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Foshan Traditional Chinese Medicine Immune Health Technology Innovation Base"},{"DOI":"10.13039\/501100021171","name":"GuangDong Basic and Applied Basic Research Foundation","doi-asserted-by":"crossref","award":["2023A1515140125"],"award-info":[{"award-number":["2023A1515140125"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003785","name":"Medical Scientific Research Foundation of Guangdong Province of China","doi-asserted-by":"crossref","award":["B2021265"],"award-info":[{"award-number":["B2021265"]}],"id":[{"id":"10.13039\/501100003785","id-type":"DOI","asserted-by":"crossref"}]},{"name":"The Science and Technology Innovation Research Program of Jinling Hospital","award":["2023JCYJZD078"],"award-info":[{"award-number":["2023JCYJZD078"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-25625-w","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T12:54:40Z","timestamp":1763988880000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Serum osteocalcin is associated with the presence of hepatic steatosis in Chinese patients with chronic hepatitis B"],"prefix":"10.1038","volume":"15","author":[{"given":"Yanting","family":"He","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijun","family":"Tong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuge","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weining","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,24]]},"reference":[{"issue":"11","key":"25625_CR1","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nrrheum.2012.157","volume":"8","author":"DJ DiGirolamo","year":"2012","unstructured":"DiGirolamo, D. J., Clemens, T. L. & Kousteni, S. The skeleton as an endocrine organ. Nat. Rev. Rheumatol. 8 (11), 674\u2013683 (2012).","journal-title":"Nat. Rev. Rheumatol."},{"issue":"9","key":"25625_CR2","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.molmed.2013.05.006","volume":"19","author":"G Musso","year":"2013","unstructured":"Musso, G., Paschetta, E., Gambino, R., Cassader, M. & Molinaro, F. Interactions among bone, liver, and adipose tissue predisposing to diabesity and fatty liver. Trends Mol. Med. 19 (9), 522\u2013535 (2013).","journal-title":"Trends Mol. Med."},{"key":"25625_CR3","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.bone.2015.05.046","volume":"82","author":"ML Zoch","year":"2016","unstructured":"Zoch, M. L., Clemens, T. L. & Riddle, R. C. New insights into the biology of osteocalcin. Bone 82, 42\u201349 (2016).","journal-title":"Bone"},{"issue":"7","key":"25625_CR4","doi-asserted-by":"publisher","first-page":"985","DOI":"10.3346\/jkms.2010.25.7.985","volume":"25","author":"YS Kim","year":"2010","unstructured":"Kim, Y. S., Paik, I. Y., Rhie, Y. J. & Suh, S. H. Integrative physiology: defined novel metabolic roles of osteocalcin. J. Korean Med. Sci. 25 (7), 985\u2013991 (2010).","journal-title":"J. Korean Med. Sci."},{"issue":"3","key":"25625_CR5","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.cell.2007.05.047","volume":"130","author":"NK Lee","year":"2007","unstructured":"Lee, N. K. et al. Endocrine regulation of energy metabolism by the skeleton. Cell 130 (3), 456\u2013469 (2007).","journal-title":"Cell"},{"issue":"11","key":"25625_CR6","doi-asserted-by":"publisher","first-page":"3225","DOI":"10.2337\/db16-0053","volume":"65","author":"JM Liu","year":"2016","unstructured":"Liu, J. M., Rosen, C. J., Ducy, P., Kousteni, S. & Karsenty, G. Regulation of glucose handling by the skeleton: insights from mouse and human studies. Diabetes 65 (11), 3225\u20133232 (2016).","journal-title":"Diabetes"},{"key":"25625_CR7","doi-asserted-by":"publisher","first-page":"873588","DOI":"10.3389\/fphar.2022.873588","volume":"13","author":"H Zhang","year":"2022","unstructured":"Zhang, H. et al. First-In-Human study on Pharmacokinetics, Safety, and tolerability of single and multiple escalating doses of Hepenofovir, a novel hepatic targeting prodrug of Tenofovir in healthy Chinese subjects. Front. Pharmacol. 13, 873588 (2022).","journal-title":"Front. Pharmacol."},{"issue":"9663","key":"25625_CR8","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/S0140-6736(09)60207-5","volume":"373","author":"YF Liaw","year":"2009","unstructured":"Liaw, Y. F. & Chu, C. M. Hepatitis B virus infection. Lancet 373 (9663), 582\u2013592 (2009).","journal-title":"Lancet"},{"issue":"4","key":"25625_CR9","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.jhep.2017.06.003","volume":"67","author":"JG Fan","year":"2017","unstructured":"Fan, J. G., Kim, S. U. & Wong, V. W. New trends on obesity and NAFLD in Asia. J. Hepatol. 67 (4), 862\u2013873 (2017).","journal-title":"J. Hepatol."},{"issue":"4","key":"25625_CR10","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.cgh.2017.09.044","volume":"16","author":"WK Seto","year":"2018","unstructured":"Seto, W. K. et al. Association between hepatic Steatosis, measured by controlled Attenuation Parameter, and fibrosis burden in chronic hepatitis B. Clin. Gastroenterol. Hepatol. 16 (4), 575\u2013583 (2018). e2.","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"5","key":"25625_CR11","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1002\/hep.28778","volume":"64","author":"JY Cheng","year":"2016","unstructured":"Cheng, J. Y. et al. Metabolic syndrome increases cardiovascular events but not hepatic events and death in patients with chronic hepatitis B. Hepatology 64 (5), 1507\u20131517 (2016).","journal-title":"Hepatology"},{"issue":"4","key":"25625_CR12","doi-asserted-by":"publisher","first-page":"885","DOI":"10.3349\/ymj.2016.57.4.885","volume":"57","author":"YE Chon","year":"2016","unstructured":"Chon, Y. E. et al. The relationship between type 2 diabetes mellitus and Non-Alcoholic fatty liver disease measured by controlled Attenuation parameter. Yonsei Med. J. 57 (4), 885\u2013892 (2016).","journal-title":"Yonsei Med. J."},{"issue":"3","key":"25625_CR13","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1111\/dme.13565","volume":"35","author":"AL Sberna","year":"2018","unstructured":"Sberna, A. L. et al. European association for the study of the liver (EASL), European association for the study of diabetes (EASD) and European association for the study of obesity (EASO) clinical practice recommendations for the management of non-alcoholic fatty liver disease: evaluation of their application in people with type 2 diabetes. Diabet. Med. 35 (3), 368\u2013375 (2018).","journal-title":"Diabet. Med."},{"issue":"4","key":"25625_CR14","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1111\/apt.15087","volume":"49","author":"A Mantovani","year":"2019","unstructured":"Mantovani, A. et al. Systematic review with meta-analysis: non-alcoholic fatty liver disease is associated with a history of osteoporotic fractures but not with low bone mineral density. Aliment. Pharmacol. Ther. 49 (4), 375\u2013388 (2019).","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"3","key":"25625_CR15","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1056\/NEJMcp1513724","volume":"374","author":"DM Black","year":"2016","unstructured":"Black, D. M. & Rosen, C. J. Clinical Practice. Postmenopausal osteoporosis. N Engl. J. Med. 374 (3), 254\u2013262 (2016).","journal-title":"N Engl. J. Med."},{"issue":"25","key":"25625_CR16","doi-asserted-by":"publisher","first-page":"4007","DOI":"10.3748\/wjg.v19.i25.4007","volume":"19","author":"L Pacifico","year":"2013","unstructured":"Pacifico, L. et al. Adipokines and C-reactive protein in relation to bone mineralization in pediatric nonalcoholic fatty liver disease. World J. Gastroenterol. 19 (25), 4007\u20134014 (2013).","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"25625_CR17","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1002\/hep.23998","volume":"53","author":"WK Syn","year":"2011","unstructured":"Syn, W. K. et al. Osteopontin is induced by Hedgehog pathway activation and promotes fibrosis progression in nonalcoholic steatohepatitis. Hepatology 53 (1), 106\u2013115 (2011).","journal-title":"Hepatology"},{"issue":"50","key":"25625_CR18","doi-asserted-by":"publisher","first-page":"e2276","DOI":"10.1097\/MD.0000000000002276","volume":"94","author":"CH Chen","year":"2015","unstructured":"Chen, C. H., Lin, C. L. & Kao, C. H. Association between chronic hepatitis B virus infection and risk of osteoporosis: A nationwide Population-Based study. Med. (Baltim). 94 (50), e2276 (2015).","journal-title":"Med. (Baltim)."},{"issue":"3","key":"25625_CR19","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1002\/hep.27894","volume":"62","author":"GL Wong","year":"2015","unstructured":"Wong, G. L. et al. Long-term safety of oral nucleos(t)ide analogs for patients with chronic hepatitis B: A cohort study of 53,500 subjects. Hepatology 62 (3), 684\u2013693 (2015).","journal-title":"Hepatology"},{"key":"25625_CR20","first-page":"41","volume":"6","author":"IF Grigsby","year":"2010","unstructured":"Grigsby, I. F., Pham, L., Mansky, L. M., Gopalakrishnan, R. & Mansky, K. C. Tenofovir-associated bone density loss. Ther. Clin. Risk Manag. 6, 41\u201347 (2010).","journal-title":"Ther. Clin. Risk Manag"},{"issue":"2","key":"25625_CR21","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1007\/s10620-014-3363-4","volume":"60","author":"C Tien","year":"2015","unstructured":"Tien, C. et al. Long-term treatment with Tenofovir in Asian-American chronic hepatitis B patients is associated with abnormal renal phosphate handling. Dig. Dis. Sci. 60 (2), 566\u2013572 (2015).","journal-title":"Dig. Dis. Sci."},{"issue":"8","key":"25625_CR22","doi-asserted-by":"publisher","first-page":"631","DOI":"10.3109\/00365513.2011.604427","volume":"71","author":"Y Yusuf","year":"2011","unstructured":"Yusuf, Y., Ramazan, K., Fatih, E. & Nese, I. Serum osteocalcin levels in patients with nonalcoholic fatty liver disease: association with ballooning degeneration. Scand. J. Clin. Lab. Investig. 71(8), 631 (2011).","journal-title":"Scand. J. Clin. Lab. Investig."},{"issue":"2","key":"25625_CR23","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1159\/000369789","volume":"91","author":"DH Sinn","year":"2015","unstructured":"Sinn, D. H. et al. Association between serum osteocalcin levels and non-alcoholic fatty liver disease in women. Digestion 91 (2), 150\u2013157 (2015).","journal-title":"Digestion"},{"issue":"4","key":"25625_CR24","doi-asserted-by":"publisher","first-page":"297","DOI":"10.14218\/JCTH.2016.00019","volume":"5","author":"J Hou","year":"2017","unstructured":"Hou, J. et al. Chinese society of Hepatology, C.M.A. Chinese society of infectious Diseases, guideline of prevention and treatment for chronic hepatitis B (2015 Update). J. Clin. Transl Hepatol. 5 (4), 297\u2013318 (2017).","journal-title":"J. Clin. Transl Hepatol."},{"issue":"9","key":"25625_CR25","doi-asserted-by":"publisher","first-page":"e0138838","DOI":"10.1371\/journal.pone.0138838","volume":"10","author":"P Schmid","year":"2015","unstructured":"Schmid, P. et al. H.I.V.C.S. Swiss, progression of liver fibrosis in HIV\/HCV Co-Infection: A comparison between Non-Invasive assessment methods and liver biopsy. PLoS One. 10 (9), e0138838 (2015).","journal-title":"PLoS One"},{"issue":"40","key":"25625_CR26","doi-asserted-by":"publisher","first-page":"6053","DOI":"10.3748\/wjg.v25.i40.6053","volume":"25","author":"G Ferraioli","year":"2019","unstructured":"Ferraioli, G., Soares, L. B. & Monteiro Ultrasound-based techniques for the diagnosis of liver steatosis. World J. Gastroenterol. 25 (40), 6053\u20136062 (2019).","journal-title":"World J. Gastroenterol."},{"issue":"9","key":"25625_CR27","doi-asserted-by":"publisher","first-page":"e0200656","DOI":"10.1371\/journal.pone.0200656","volume":"13","author":"N Fabrellas","year":"2018","unstructured":"Fabrellas, N. et al. Prevalence of hepatic steatosis as assessed by controlled Attenuation parameter (CAP) in subjects with metabolic risk factors in primary care. A population-based study. PLoS One. 13 (9), e0200656 (2018).","journal-title":"PLoS One"},{"issue":"6","key":"25625_CR28","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1007\/s00125-011-2155-z","volume":"54","author":"P Ducy","year":"2011","unstructured":"Ducy, P. The role of osteocalcin in the endocrine cross-talk between bone remodelling and energy metabolism. Diabetologia 54 (6), 1291\u20131297 (2011).","journal-title":"Diabetologia"},{"issue":"5","key":"25625_CR29","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1530\/EJE-09-0585","volume":"161","author":"M Zhou","year":"2009","unstructured":"Zhou, M. et al. Serum osteocalcin concentrations in relation to glucose and lipid metabolism in Chinese individuals. Eur. J. Endocrinol. 161 (5), 723\u2013729 (2009).","journal-title":"Eur. J. Endocrinol."},{"issue":"7503","key":"25625_CR30","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/nature13478","volume":"510","author":"RJ Perry","year":"2014","unstructured":"Perry, R. J., Samuel, V. T., Petersen, K. F. & Shulman, G. I. The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes. Nature 510 (7503), 84\u201391 (2014).","journal-title":"Nature"},{"issue":"4","key":"25625_CR31","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1007\/s00198-011-1679-x","volume":"23","author":"YC Hwang","year":"2012","unstructured":"Hwang, Y. C., Jeong, I. K., Ahn, K. J. & Chung, H. Y. Circulating osteocalcin level is associated with improved glucose tolerance, insulin secretion and sensitivity independent of the plasma adiponectin level. Osteoporos. Int. 23 (4), 1337\u20131342 (2012).","journal-title":"Osteoporos. Int."},{"issue":"10","key":"25625_CR32","doi-asserted-by":"publisher","first-page":"19782","DOI":"10.3390\/ijms141019782","volume":"14","author":"JJ Liu","year":"2013","unstructured":"Liu, J. J. et al. Relationship between serum osteocalcin levels and non-alcoholic fatty liver disease in adult males, South China. Int. J. Mol. Sci. 14 (10), 19782\u201319791 (2013).","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"25625_CR33","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1111\/1440-1681.12063","volume":"40","author":"J Dou","year":"2013","unstructured":"Dou, J. et al. Relationship between serum osteocalcin levels and non-alcoholic fatty liver disease in Chinese men. Clin. Exp. Pharmacol. Physiol. 40 (4), 282\u2013288 (2013).","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"6","key":"25625_CR34","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1177\/0022034513485600","volume":"92","author":"SN Pramojanee","year":"2013","unstructured":"Pramojanee, S. N., Phimphilai, M., Kumphune, S., Chattipakorn, N. & Chattipakorn, S. C. Decreased jaw bone density and osteoblastic insulin signaling in a model of obesity. J. Dent. Res. 92 (6), 560\u2013565 (2013).","journal-title":"J. Dent. Res."},{"issue":"2","key":"25625_CR35","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1182\/blood-2009-11-255026","volume":"116","author":"H Li","year":"2010","unstructured":"Li, H. et al. Cross talk between the bone and immune systems: osteoclasts function as antigen-presenting cells and activate CD4\u2009+\u2009and CD8\u2009+\u2009T cells. Blood 116 (2), 210\u2013217 (2010).","journal-title":"Blood"},{"issue":"1","key":"25625_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbrc.2008.10.146","volume":"378","author":"NS Soysa","year":"2009","unstructured":"Soysa, N. S. & Alles, N. NF-kappaB functions in osteoclasts. Biochem. Biophys. Res. Commun. 378 (1), 1\u20135 (2009).","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"11","key":"25625_CR37","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/nrgastro.2009.166","volume":"6","author":"IA Nakchbandi","year":"2009","unstructured":"Nakchbandi, I. A. & van der Merwe, S. W. Current Understanding of osteoporosis associated with liver disease. Nat. Rev. Gastroenterol. Hepatol. 6 (11), 660\u2013670 (2009).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"4","key":"25625_CR38","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/S8756-3282(03)00237-0","volume":"33","author":"L Lenchik","year":"2003","unstructured":"Lenchik, L. et al. Adiponectin as a novel determinant of bone mineral density and visceral fat. Bone 33 (4), 646\u2013651 (2003).","journal-title":"Bone"},{"issue":"3","key":"25625_CR39","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1093\/infdis\/jiu471","volume":"211","author":"US Gill","year":"2015","unstructured":"Gill, U. S. et al. Assessment of bone mineral density in tenofovir-treated patients with chronic hepatitis B: can the fracture risk assessment tool identify those at greatest risk? J. Infect. Dis. 211 (3), 374\u2013382 (2015).","journal-title":"J. Infect. Dis."},{"issue":"1","key":"25625_CR40","doi-asserted-by":"publisher","first-page":"451","DOI":"10.3906\/sag-1805-233","volume":"49","author":"R Guner","year":"2019","unstructured":"Guner, R., Kocak Tufan, Z., Yilmaz, G. R. & Mehmet, A. T. Tenofovir disoproxil fumarate May not cause renal and bone toxicity in chronic hepatitis B patients: a retrospective cross-sectional study. Turk. J. Med. Sci. 49 (1), 451\u2013452 (2019).","journal-title":"Turk. J. Med. Sci."},{"issue":"1","key":"25625_CR41","doi-asserted-by":"publisher","first-page":"35","DOI":"10.5152\/tjg.2020.18024","volume":"33","author":"R Kahraman","year":"2022","unstructured":"Kahraman, R. et al. Effects of Long-Term Tenofovir and Entecavir treatment on bone mineral density in patients with chronic hepatitis B. Turk. J. Gastroenterol. 33 (1), 35\u201343 (2022).","journal-title":"Turk. J. Gastroenterol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25625-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25625-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25625-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T01:02:20Z","timestamp":1764378140000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25625-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,24]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["25625"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-25625-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5475493\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,24]]},"assertion":[{"value":"18 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Due to the retrospective nature of the study, (full name of IRB) waived the need of obtaining informed consent. Our research was approved by the Ethics Committee of Guangdong Provincial Hospital of Integrated Traditional Chinese and Western Medicine (Approval number: 2018\u2009\u2212\u20091254), and it strictly adhered to the principles outlined in the Declaration of Helsinki. Due to the retrospective, observational, and anonymous characteristics of the study, the requirement for obtaining written informed consent from participants was formally waived by the Ethics Committee of Guangdong Provincial Hospital of Integrated Traditional Chinese and Western Medicine.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics and consent"}}],"article-number":"41641"}}